SEC Info - Global Blood Therapeutics, Inc. - ‘8-K’ for 6/14/21

SEC Info℠

Home

Help

Please Sign In

Global Blood Therapeutics, Inc. – ‘8-K’ for 6/14/21 – ‘XML’

On: Monday, 6/14/21, at 7:01am ET · For: 6/14/21 · Accession #: 1171843-21-4301 · File #: 1-37539

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/14/21  Global Blood Therapeutics, Inc.   8-K:8,9     6/14/21   12:229K                                   Globenewswire Inc./FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     19K 
 2: EX-99.1     Press Release                                       HTML     22K 
 8: R1          Cover                                               HTML     44K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- f8k_061221_htm                      XML     14K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.DEF  XBRL Definitions -- gnw-20190101_def                 XML     71K 
 5: EX-101.LAB  XBRL Labels -- gnw-20190101_lab                      XML     99K 
 6: EX-101.PRE  XBRL Presentations -- gnw-20190101_pre               XML     68K 
 3: EX-101.SCH  XBRL Schema -- gnw-20190101                          XSD     13K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               26±    34K 
12: ZIP         XBRL Zipped Folder -- 0001171843-21-004301-xbrl      Zip     18K

‘XML’ — XBRL Instance — f8k_061221_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="gnw-20190101.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

</unit>

<measure> shares </measure>

</unit>

</unitNumerator>

<measure> shares </measure>

</unitDenominator>

</divide>

</unit>

<dei:EntityCentralIndexKey contextRef="Form8K"> 0001629137 </dei:EntityCentralIndexKey>

<dei:AmendmentFlag contextRef="Form8K"> false </dei:AmendmentFlag>

<dei:DocumentType contextRef="Form8K"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="Form8K"> 2021-06-14 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="Form8K"> Global Blood Therapeutics, Inc. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="Form8K"> DE </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="Form8K"> 001-37539 </dei:EntityFileNumber>

<dei:EntityTaxIdentificationNumber contextRef="Form8K"> 27-4825712 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="Form8K"> 181 Oyster Point Blvd. </dei:EntityAddressAddressLine1>

<dei:EntityAddressCityOrTown contextRef="Form8K"> South San Francisco </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="Form8K"> CA </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="Form8K"> 94080 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="Form8K"> 650 </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="Form8K"> 741-7700 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="Form8K"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="Form8K"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="Form8K"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="Form8K"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="Form8K"> Common Stock, par value $0.001 per share </dei:Security12bTitle>

<dei:TradingSymbol contextRef="Form8K"> GBT </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="Form8K"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="Form8K"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/31/22  Global Blood Therapeutics, Inc.   S-8         1/31/22    6:595K                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0001171843-21-004301 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Global Blood Therapeutics, Inc. – ‘8-K’ for 6/14/21 – ‘XML’

On: Monday, 6/14/21, at 7:01am ET · For: 6/14/21 · Accession #: 1171843-21-4301 · File #: 1-37539

Previous ‘8-K’: ‘8-K’ on / for 6/11/21 · Next: ‘8-K’ on / for 6/17/21 · Latest: ‘8-K’ on / for 10/5/22 · 1 Reference: By: Global Blood Therapeutics, Inc. – ‘S-8’ on 1/31/22

Current Report — Form 8-KFiling Table of Contents

‘XML’ — XBRL Instance — f8k_061221_htm

This Document is an XBRL XML File.

1 Subsequent Filing that References this Filing

Current Report — Form 8-K

Filing Table of Contents